The Coach Mpilo Study: Evaluation of a Peer-led Intervention to Promote Engagement in HIV Care for Men Living With HIV in South Africa
1 other identifier
interventional
800
1 country
1
Brief Summary
Developed in South Africa using extensive input from community members and healthcare professionals, Coach Mpilo is a peer support intervention that was designed to improve health outcomes for men living with HIV. Coach Mpilo engages men living with HIV as coaches who provide support to their peers and help them address psychosocial barriers in accessing and staying in HIV care. The peers employed by Coach Mpilo provide individualized assistance to men who are struggling with medication adherence and clinic visits, focusing on specific barriers ranging from knowledge about the benefits of HIV treatment, stigma, mental health, and social isolation. Through a randomised control trial, this project will (1) determine the impact of the Coach Mpilo intervention on retention in HIV care, viral suppression, HIV treatment adherence, mental health, HIV stigma, and economic status; (2) identify populations of men who may not benefit from the intervention and require alternative support; and (3) assess the intervention's cost-effectiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hiv
Started May 2026
Shorter than P25 for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 26, 2026
CompletedFirst Posted
Study publicly available on registry
May 4, 2026
CompletedStudy Start
First participant enrolled
May 11, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
Study Completion
Last participant's last visit for all outcomes
September 1, 2027
May 4, 2026
April 1, 2026
1.3 years
April 26, 2026
April 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retention in HIV care
Indicates whether a participant attended a follow-up clinic visit on or before 12 months after study enrolment and obtained adequate supply of antiretroviral therapy (ART) medication to have medication available at 12 months
12 months post study enrolment
Secondary Outcomes (14)
ART clinic visit by 6 months
6 months post study enrolment
Retention in HIV care at 6 months
6 months post study enrolment
Viral load test completed at 6 months
6 months post study enrolment
Viral suppression at 6 months
3 to 9 months post study enrolment
Viral suppression at 12 months
9 to 15 months post study enrolment
- +9 more secondary outcomes
Study Arms (2)
Control group
NO INTERVENTIONStandard of care (SOC) in our study is a once-off telephonic contact by a Study Linkage Officer to encourage the participant to return to HIV care. The Linkage Officer is trained to conduct the call in line with the South African National Guidelines on tracing and recall which involved making telephonic contact with an individual who has missed their HIV clinic appointment by 7 days. The National Guidelines for tracing also include a potential home visit if the telephone call is unsuccessful. Given our study sample is limited to men who have missed HIV clinic appointments by more than 28 days, all participants should already have received the standard tracing services provided by the health facility. In the study we conduct the tracing telephone call again to make sure all participants have received this service. No other intervention is provided.
Coach Mpilo group
EXPERIMENTALThe experimental group receives the standard of care for the control group (see control group description) and the Coach Mpilo intervention. Coach Mpilo employs 'coaches' (a term found to resonate with men and the concept of 'getting back in the game') to work 1-on-1 with men living with HIV ('players') and tailor support for each man to help him re-engage and stay in care. Coaches provide support for a period of up to six months, during which they engage with clients about once every week, with greater contact as needed based on the complexity of challenges faced. Coach Mpilo provides one-on-one, in-person support tailored to the individual needs of men living with HIV. As such, it may address the complex and varying psychosocial barriers to HIV care that traditional clinic-based interventions typically overlook. Coach Mpilo employs men living openly with HIV as coaches. This leverages the coaches' personal experiences to create a safe and supportive environment for clients.
Interventions
The experimental group receives the standard of care for the control group (see control group description) and the Coach Mpilo intervention. Coach Mpilo employs 'coaches' (a term found to resonate with men and the concept of 'getting back in the game') to work 1-on-1 with men living with HIV ('players') and tailor support for each man to help him re-engage and stay in care. Coaches provide support for a period of up to six months, during which they engage with clients about once every week, with greater contact as needed based on the complexity of challenges faced. Coach Mpilo provides one-on-one, in-person support tailored to the individual needs of men living with HIV. As such, it may address the complex and varying psychosocial barriers to HIV care that traditional clinic-based interventions typically overlook. Coach Mpilo employs men living openly with HIV as coaches. This leverages the coaches' personal experiences to create a safe and supportive environment for clients.
Eligibility Criteria
You may qualify if:
- Male (cisgender or transgender);
- aged ≥18 years;
- previously receiving HIV care at the study clinic;
- missed their most recent ART (antiretroviral therapy) clinic appointment by \>28 days;
- not planning to relocate to another region within the next 12 months;
- able and willing to provide informed consent;
- not currently taking ART
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Cape Townlead
- University of Pennsylvaniacollaborator
- University of the Witwatersrand, South Africacollaborator
Study Sites (1)
Multisite study with several health care facilities
Durban, KwaZulu-Natal, South Africa
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Brendan G Maughan-Brown, PhD
University of Cape Town
- PRINCIPAL INVESTIGATOR
Harsha Thirumurthy, PhD
University of Pennsylvania
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Research Officer
Study Record Dates
First Submitted
April 26, 2026
First Posted
May 4, 2026
Study Start (Estimated)
May 11, 2026
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2027
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Data will be made publicly available through DataFirst within 12 months from the data collection for the study
- Access Criteria
- Data will be available through DataFirst. Individuals who successfully register with DataFirst will have access. There are no specific exclusion criteria
Survey data and in-depth interview data; excluding personal identifying information